| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.3 |